Advertisement

Gastroesophageal Cancer

ASCO GI 2017: PET Scans Can Inform and Improve Treatment for Patients With Esophageal Cancer

Findings from a federally funded clinical trial—CALGB 80803 (Alliance)—point to a new way to improve the outlook for patients with esophageal cancer: using positron-emission tomography (PET) scans...

 

Colorectal Cancer

ASCO GI 2017: Physical Activity May Be Linked to Longer Survival in Advanced Colorectal Cancer

A new analysis of the CALGB 80405 (Alliance) trial suggests that people with metastatic colorectal cancer who are more physically active fare better than those who are less active...

Colorectal Cancer

ASCO GI 2017: Watch-and-Wait Approach for Rectal Cancer Appears an Option for More Patients

Real-world data from a large observational study suggests that omitting surgery in strictly selected patients with a clinical complete response does not compromise outcomes in rectal cancer...


Advertisement

More Top Stories

Lymphoma
Geriatric Oncology

Catherine Thieblemont, MD, PhD, and Julie Vose, MD, MBA, on DLBCL: Results From the Lysa Remarc Study

Breast Cancer

Confirmation or Transformation? The Case of Palbociclib in Hormone Receptor–Positive Metastatic Breast Cancer

Women with hormone receptor–positive metastatic breast cancer are witnessing an unprecedented time of success in the battle against their disease. Just in the past 12 months, a number of prospective, randomized, phase III studies were reported, with positive results indicating the value of...

Advertisement

ASCO GI 2017: Watch-and-Wait Approach for Rectal Cancer Appears an Option for More Patients

Real-world data from a large observational study suggests that omitting surgery in strictly selected patients with a clinical complete response does not compromise outcomes in rectal cancer. The 3-year survival rate among patients who received “watch-and-wait” care after initial cancer...

Breast Cancer
Symptom Management

Patricia A. Ganz, MD: Aromatase Inhibitors Data Review

Conquer Cancer Foundation Matching Gift Challenge Offers Chance to Double Your Impact

The Conquer Cancer Foundation has an incredible opportunity for you to make an amazing impact!

An anonymous donor is offering a Matching Gift Challenge, which will double the value of every gift we receive by December 31—dollar for dollar—up to $64,000! This amount is enough to fund one of our...

ASCO and ONS Release Updated Chemotherapy Administration Standards to Include Pediatric Oncology Care

ASCO and the Oncology Nursing Society (ONS) have updated their chemotherapy administration safety standards to include pediatric oncology care. The updated standards can be found in the Journal of Oncology Practice.1

In 2009, ASCO and the Oncology Nursing Society published the initial set of...

ASCO GI 2017: Physical Activity May Be Linked to Longer Survival in Advanced Colorectal Cancer

A new analysis of the CALGB 80405 (Alliance) trial suggests that people with metastatic colorectal cancer who are more physically active fare better than those who are less active. In a large clinical trial, patients who at the time of starting chemotherapy reported engaging in physical activity...

Leukemia
Survivorship

Smita Bhatia, MD, MPH, and Jessica Wu, BA, on CML: A Report From the Bone Marrow Transplant Survivor Study

Prostate Cancer
Issues in Oncology

A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?

The diagnosis and treatment of prostate cancer have long been a source of controversy among the oncology community, the political sector, and patient advocacy groups. Most notably, the decision to biopsy a man’s prostate gland rests largely on his prostate-specific antigen (PSA) test numbers, the ...

Advertisement

ASCO GI 2017: PET Scans Can Inform and Improve Treatment for Patients With Esophageal Cancer

Findings from a federally funded clinical trial—CALGB 80803 (Alliance)—point to a new way to improve the outlook for patients with esophageal cancer: using positron-emission tomography (PET) scans to assess tumor response to initial chemotherapy may allow doctors to tailor further...


click me